상세 보기
이수현
Lee, SOOHYEON
연구분야
- Clinical trials,
- Colorectal cancer, Breast cancer,
- Oncology,
- 대장암 유방암,
- 임상연구,
- 종양학
자료 필터
자료유형
발행연도
2007 ~ 2031
2007 2031
키워드
언어
전체 185건 중 41번부터 50번까지의 결과를 표시합니다.
2025
Article
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
- Hecht, J. Randolph ;
- Park, Young Suk ;
- Tabernero, Josep ;
- Lee, Myung-Ah ;
- Lee, Soohyeon ;
- 외 14명
- 2025-11
- The Lancet
- Elsevier Science Inc.
Conference
2-year follow-up of zanidatamab (Zani)+mFOLFOX6 ±bevacizumab (Bev) infirst-line(1L) treatment of patients(Pts) with human epidermal growth factor receptor 2-positive (HER2+) advanced/metastatic colorectal cancer (mCRC)
- Rha, S. Y. ;
- Lee, K-W ;
- Lee, S. ;
- Kang, Y-K. ;
- Chandana, S. ;
- 외 4명
- 2025-10-19
- 네덜란드
Conference
BTN1A1-targeted immunotherapy enhances standard treatment efficacy in NSCLC and colorectal cancer: Insights from patient-derived organoids and zebrafish models
- Lee, S-H. ;
- Kim, Y-S. ;
- Wu, C. ;
- Hong, B-K. ;
- Park, A. H. ;
- ... Lee, SOOHYEON ;
- 외 3명
- 2025-10-19
- 네덜란드
Conference
BTN1A1 H-score and multiplex biomarker profiling predict clinical benefit from nelmastobart plus capecitabine in advanced colorectal cancer: Phase Ib/II study
- Lee, SOOHYEON ;
- Hong, B. K. ;
- Wu, C. ;
- Lee, S. H. ;
- Kim, Y. S. ;
- 외 3명
- 2025-10
- 독일
Article
Comparative immunohistochemical expression of TROP2 in brain metastatic and primary tumors
- Sung, You-Na ;
- Sim, Jongmin ;
- Oh, Harim ;
- Lee, Ji Won ;
- Kim, Jwa Hoon ;
- ... Lee, Soohyeon ;
- ... Choi, Yoon Ji ;
- ... Park, Kyong Hwa ;
- ... Kim, Ju Won
- 2025-09
- American Journal of Cancer Research
- e-Century Publishing Corporation
Article
Gut microbiome with RAS mutation and chemotherapy response in patients with advanced or metastatic colorectal cancer: a pilot, exploratory study
- Kim, Jwa Hoon ;
- Kim, Boyeon ;
- Lee, Jiwon ;
- Kim, Jin ;
- Kwak, Jung-Myun ;
- ... Lee, Soohyeon
- 2025-09
- Frontiers in Oncology
- Frontiers Media S.A.